Evofem Biosciences Profit Margin 2013-2022 | EVFM
Current and historical gross margin, operating margin and net profit margin for Evofem Biosciences (EVFM) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Evofem Biosciences net profit margin as of March 31, 2022 is -1676.29%.
| Evofem Biosciences Annual Profit Margins |
| Evofem Biosciences Quarterly Profit Margins |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.013B |
$0.008B |
|
Evofem Biosciences Inc. develops and anticipates commercializing products which support and promote women as the primary healthcare consumer. The company is identifying and developing new and novel products which specifically address unmet needs in the areas of sexual and reproductive health, the prevention of acquisition of sexually transmitted infections and products which address or promote general health and wellbeing. Evofem Biosciences Inc., formerly known as Neothetics Inc., is based in SAN DIEGO CA.
|
